Cart
sales@molnova.com
Debio-0123
CAS No. 2243882-74-6
Debio-0123( —— )
Catalog No. M37689 CAS No. 2243882-74-6
Debio-0123 (WEE1-IN-5) is a potent, orally available and highly specific WEE1 inhibitor with an IC 50 in the low nanomolar range.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 256 | In Stock |
|
| 5MG | 227 | In Stock |
|
| 10MG | 313 | In Stock |
|
| 25MG | 537 | In Stock |
|
| 50MG | 728 | In Stock |
|
| 100MG | 995 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDebio-0123
-
NoteResearch use only, not for human use.
-
Brief DescriptionDebio-0123 (WEE1-IN-5) is a potent, orally available and highly specific WEE1 inhibitor with an IC 50 in the low nanomolar range.
-
DescriptionWEE1-IN-5 is a potent WEE1 inhibitor with an IC50 value of 0.8 nM. WEE1-IN-5 inhibits phospho-CDC2. WEE1-IN-5 abrogates the G2 check point, increasing sensitivity to DNA damaging agentsin cancer cells. WEE1-IN-5 can be used for researching anticancer.
-
In VitroWEE1-IN-5 exhibits an EC50 of 188 nM in pCDC2 and an IC50 shift for CYP3A4/5.
-
In VivoWEE1-IN-5 (5mg/kg for PO; 1 mg/kg for IV; single dosage) exhibits a CL of 14 mL/min/kg, an AUCint 1324 h·ng/mL and bioavailability of 35% in SD rats.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetWee1
-
RecptorWee1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2243882-74-6
-
Formula Weight511.45
-
Molecular FormulaC26H28Cl2N6O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 20 mg/mL (39.10 mM; Ultrasonic (<60°C); )
-
SMILESCN1CCC(CC1)c1ccc(Nc2ncc3C(=O)N(CN(C)c3n2)c2c(Cl)cccc2Cl)cc1C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. H. Gelderblom, et al. 601TiP First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours. Ann Oncol. 2020 Sep; 31: S501-S502.
molnova catalog
related products
-
ZN-c3
ZN-c3 is a potent and selective Wee1 inhibitor with balanced potency, ADME, and pharmacokinetic properties.
-
RP-6306
Lunresertib (RP-6306) is a potent, selective, and orally active PKMYT1 inhibitor with an IC50 of 14 nM. Lunresertib (RP-6306) inhibits the growth of CCNE1-amplified tumor cells in several preclinical xenograft models.
-
Adavosertib
A potent and selective small-molecule inhibitor of Wee1 kinase with IC50 of 5.2 nM.
